RxDoctor Payments Data

Gregory Pippin, MD

Otolaryngology · McComb, MSNPI 1700966090

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,090 of the $6,479 with a category attached, or 78.6%. 22 manufacturers reported payments, led by Aerin Medical Inc. at 32.2% of the total. 2025 is the largest year on record at $1,806, 3.7 times the $492 reported in 2019. Among otolaryngology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,479in general payments, 2019–2025

Across 134 payments — averaging $48.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • Stryker$1K
  • Smith+Nephew$1K
  • Ambu A/s$505
  • Acclarent, Inc$274
  • Intersect ENT, Inc.$266
  • plus $1K from 16 others
$70in research payments, 2019–2025

Across 2 payments — averaging $35.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$70

What the payments were for

  • Speaking & faculty fees$5058%
  • Travel & lodging$88414%
  • Food & beverage$5,09079%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,479 in reported general payments places this provider in the 95th percentile of 97 otolaryngology providers in Mississippi.

See all otolaryngology providers in Mississippi

Medicare billing

Part B allowed, 2024
$87,809
Medicare patients
97
Services billed
1,121

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide193$4,633
Sucralfate16$1,576
Fluticasone Propionate105$1,439
Pantoprazole Sodium113$1,162
Azelastine Hcl39$1,043
Levocetirizine Dihydrochloride37$835
Prednisolone Acetate25$832
Doxycycline Hyclate41$612
Albuterol Sulfate HfaAlbuterol Sulfate26$546
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$253
Ondansetron OdtOndansetron34$238
Omeprazole19$227
Montelukast Sodium26$217
Cephalexin30$208
Methylprednisolone14$124

Paid to pharmacies, not to this prescriber.

Other otolaryngology in McComb

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →